Cebpb Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Symbol | CEBPB |
|---|---|
| Full Name | CCAAT/Enhancer Binding Protein Beta |
| Chromosome | 20q13.13 |
| NCBI Gene ID | 1051 |
| OMIM | 116898 |
| Ensembl ID | ENSG00000172216 |
| UniProt ID | P17676 |
CCAAT/Enhancer Binding Protein Beta (CEBPB) is a transcription factor belonging to the CCAAT/Enhancer Binding Protein (C/EBP) family. This family of basic leucine zipper (bZIP) transcription factors is involved in the regulation of genes involved in inflammation, immune response, metabolism, cell differentiation, and proliferation.
The C/EBP family proteins are transcription factors that bind to CCAAT motifs in gene promoters and enhancers. They function as homo- or heterodimers and regulate gene expression through their leucine zipper DNA-binding domains.
CEBPB is expressed in various tissues including brain, where it plays important roles in:
In the brain, CEBPB is primarily expressed in:
Expression is often upregulated in response to inflammatory stimuli, injury, or disease states.
CEBPB has been implicated in several neurodegenerative and inflammatory diseases:
| Disease | Role | Evidence |
|---|---|---|
| Alzheimer's Disease | Neuroinflammation | Upregulated in AD brain; regulates inflammatory cytokines |
| Parkinson's Disease | Glial activation | Altered expression in PD models; contributes to neuroinflammation |
| Multiple Sclerosis | Demyelination | Regulates immune cell function; implicated in MS pathogenesis |
| Amyotrophic Lateral Sclerosis | Neuroinflammation | Altered in ALS models and patient tissue |
The involvement in neurodegeneration is primarily related to the regulation of inflammatory processes and glial cell function.
Targeting CEBPB signaling pathways may offer therapeutic strategies for neurodegenerative diseases:
The study of Cebpb Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.